LycoRed's genistein and tomato lycopene formulation boosts bone health

Selezionata da Pietro Cazzola

LycopeneThe Israel-based LycoRed has recently launched Lyc-O-Fem, a slow-release formulation containing genistein, tomato lycopene and Vitamin D3 in a new proprietary composition for bone health. The combination also provides a natural approach to alleviate menopause symptoms.
The genistein in Lyc-O-Fem is a phytoestrogen derived from sophora japonica, the Japanese pagoda tree, and is standardised to 98 per cent purity and specially formulated for slow release. The compound has been shown in research studies to support bone health and reduce vasomotor symptoms.
Studies back the positive effect of genistein on bone metabolism in post-menopausal women, without the harmful estrogenic activity. But genistein is rapidly metabolised, requiring a twice-daily administration of the supplement. The slow-release technology in LycoRed’s preparation provides a continuous exposure, allowing once-a-day supplementation.
“The advantage in combining the slow-release formulation of pure genistein with natural tomato lycopene, in addition to the cumulative activity in bone maintenance, is the ability of lycopene derivatives to reduce the risk of certain adverse effects associated with estrogenic activity,” Tal Offer, product development manager, LycoRed, said.
Lycopene is a bright-red carotenoid pigment. Lyc-O-Fem contained lycopene from an all-natural extract of tomatoes. To develop a strain of non-genetically modified tomatoes rich in lycopene up to four times the amount found in regular tomatoes conventional cross-breeding methods were used and a proprietary method for extracting the tomato lycopene from these tomatoes was developed. Lyc-O-Fem is available as a drum-to-hopper pre-mix, in hard-shell capsules or as a bulk or fully-packed product.